Skip to content

AI in clinical trials

Artificial intelligence is reshaping the landscape of clinical trials, offering unprecedented opportunities to enhance efficiency, reduce costs and improve patient outcomes.Published 13 Feb 2025 · 2 min read
Scientist in full protective gear

Artificial intelligence (AI) refers to computer systems designed to perform tasks that typically require human intelligence. Machine learning, a subset of AI, enables systems to learn from data and improve understanding over time without explicit programming. Generative AI builds on that foundation and can learn human language, programming languages, chemistry, biology or any complex subject matter.

The use of AI in clinical trials

Clinical trials are research studies involving human participants which aim to evaluate medical, surgical or behavioural interventions. They are essential for determining the safety and efficacy of new treatments, drugs and procedures before they become widely available.

The integration of AI into clinical trials is transforming the research landscape in several ways:

Predictive modelling

Machine learning in clinical trials can predict potential outcomes based on existing data, aiding in decision-making and risk assessment throughout the trial process.

Trial design optimisation

AI assists in designing trials by analysing previous studies and real-world data to determine optimal sample sizes, endpoints and methodologies, thereby reducing costs and improving success rates.

Data monitoring and analysis

During trials, AI monitors data in real-time, identifying anomalies or trends that may require attention.

Patient recruitment and matching

AI can swiftly analyse electronic health records to identify suitable candidates for trials, enhancing recruitment efficiency and ensuring diverse participant representation. For instance, the US National Institutes of Health has developed an AI algorithm called TrialGPT that matches potential volunteers to clinical trials, improving enrolment processes.

Benefits of artificial intelligence in clinical trials

The incorporation of AI into clinical trials offers numerous advantages:

Increased efficiency

Automating complex tasks accelerates trial processes, reducing the time required to bring new treatments to market.

Cost reduction

By streamlining operations and minimising errors, AI reduces the financial burden associated with clinical research.

Improved patient safety

Early detection of adverse events through AI monitoring enhances participant safety and allows for prompt interventions.

Better decision-making

The use of AI in medical research enhances the overall decision-making process, from trial design to data interpretation, leading to more effective and targeted therapies.

Generative AI in clinical trials

Recent breakthroughs in generative AI could further enhance trial simulations and predictive modelling. Moreover, ongoing research aims to improve AI’s capabilities in understanding complex biological systems, potentially leading to personalised medicine tailored to individual patient profiles.

According to the World Economic Forum, unlocking generative AI's full potential could save billions of dollars, while speeding up the delivery of lifesaving treatments. As technology advances, the collaboration between AI and clinical research is set to drive significant medical breakthroughs, ultimately benefiting patients worldwide.

  • Take a deep dive into Norway’s health and life science industry

    Norway offers pioneering health solutions, with particular strengths in biopharma, medtech and digital health. Click to read articles, discover solution providers and find events where you can meet Norwegian companies.

    Health and life science